Cochrane · systematic review · CD003839

Self‐monitoring and self‐management of oral anticoagulation

Heneghan, CJ, Garcia-Alamino, JM, Spencer, EA, et al. · Cochrane Database of Systematic Reviews · 2016 · Cochrane Library

HeartAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
12
current version
GRADE rated
12
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 0 · 0%Low 4 · 33.3%Moderate 8 · 66.7%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Self‐monitoring or self‐management of oral anticoagulation vs. standard care

Population: Patients on long‐term anticoagulant therapy (treatment duration longer than two months) irrespective of the indication for treatment
4 questions
OutcomeEffectEvidenceStatus / GRADE
Thromboembolic events
Self‐monitoring or self‐management of oral anticoagulation vs standard care
RR 0.58 [0.45, 0.74]18 studies · 7594 participantsModerate
Downgraded: risk of bias
All‐cause mortality
Self‐monitoring or self‐management of oral anticoagulation vs standard care
RR 0.85 [0.71, 1.01]11 studies · 6358 participantsModerate
Downgraded: risk of bias
Major haemorrhage
Self‐monitoring or self‐management of oral anticoagulation vs standard care
RR 0.95 [0.8, 1.12]20 studies · 8018 participantsModerate
Downgraded: risk of bias
Minor haemorrhage
Self‐monitoring or self‐management of oral anticoagulation vs standard care
RR 0.97 [0.67, 1.41]13 studies · 5365 participantsLow
Downgraded: risk of bias, inconsistency

Self‐monitoring of oral anticoagulation vs. standard care

Population: Patients on long‐term anticoagulant therapy (treatment duration longer than two months) irrespective of the indication for treatment
4 questions
OutcomeEffectEvidenceStatus / GRADE
Thromboembolic events
Self‐monitoring of oral anticoagulation vs standard care
RR 0.69 [0.49, 0.97]7 studies · 4097 participantsModerate
Downgraded: risk of bias, publication bias
All‐cause mortality
Self‐monitoring of oral anticoagulation vs standard care
RR 0.94 [0.78, 1.15]3 studies · 3300 participantsModerate
Downgraded: risk of bias, publication bias
Major haemorrhage
Self‐monitoring of oral anticoagulation vs standard care
RR 0.9 [0.74, 1.09]7 studies · 4038 participantsLow
Downgraded: risk of bias, publication bias
Minor haemorrhage
Self‐monitoring of oral anticoagulation vs standard care
RR 1.16 [0.95, 1.42]6 studies · 3503 participantsModerate
Downgraded: risk of bias, publication bias

self‐management of oral anticoagulation vs. standard care

Population: Patients on long‐term anticoagulant therapy (treatment duration longer than two months) irrespective of the indication for treatment
4 questions
OutcomeEffectEvidenceStatus / GRADE
Thromboembolic events
self‐management of oral anticoagulation vs standard care
RR 0.47 [0.31, 0.7]11 studies · 3497 participantsModerate
Downgraded: risk of bias, imprecision, inconsistency
All‐cause mortality
self‐management of oral anticoagulation vs standard care
RR 0.55 [0.36, 0.84]8 studies · 3058 participantsModerate
Downgraded: risk of bias, imprecision, inconsistency
Major haemorrhage
self‐management of oral anticoagulation vs standard care
RR 1.08 [0.79, 1.47]13 studies · 3980 participantsLow
Downgraded: risk of bias, imprecision
Minor haemorrhage
self‐management of oral anticoagulation vs standard care
RR 0.91 [0.47, 1.76]7 studies · 1862 participantsLow
Downgraded: risk of bias, imprecision, inconsistency